Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

CDXS - Codexis Inc.


IEX Last Trade
2.9
0   0%

Share volume: 215,841
Last Updated: Fri 30 Aug 2024 10:00:00 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) : 0.87%

PREVIOUS CLOSE
CHG
CHG%

$2.90
0.00
0.00%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
12%
Profitability 8%
Dept financing 11%
Liquidity 75%
Performance 0%
Company vs Stock growth
vs
Performance
5 Days
-5.25%
1 Month
-20.39%
3 Months
-15.00%
6 Months
-22.31%
1 Year
64.20%
2 Year
-59.07%
Key data
Stock price
$2.90
P/E Ratio 
0.00
DAY RANGE
N/A - N/A
EPS 
$0.00
52 WEEK RANGE
$1.45 - $4.91
52 WEEK CHANGE
$0.61
MARKET CAP 
204.980 M
YIELD 
N/A
SHARES OUTSTANDING 
70.927 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/07/2024
BETA 
2.48
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$227,978
AVERAGE 30 VOLUME 
$350,141
Company detail
CEO:
Region: US
Website: https://www.cedexis.com/
Employees: 336
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services

codexis, inc. is a leading protein engineering company applying innovative technologies to unlock the power of proteins™. our proprietary codeevolver® technology platform enables the rapid development and production of highly optimized proteins, custom-designed for your application. codexis’ revolutionary approach to protein engineering starts with an understanding of the desired performance specifications and optimizes a protein specifically to fit these requirements. you get precisely the protein you need for the job you want it to do. guided by proprietary artificial intelligence software and advanced high-throughput screening systems, codexis is able to efficiently generate and introduce function-driven mutations to rapidly improve a protein for its target application. since 2002, codexis’ in-house biochemists, biologists and bioinformatics experts have worked closely with our clients to advance the technologies for protein optimization and production, enabling breakthrough develop

Recent news